Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson’s disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial

Overview of attention for article published in Pilot and Feasibility Studies, August 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 11 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 12 X posts from 11 X users, with an upper bound of 35,809 followers.

Open Access UCL Research: Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson’s disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial https://t.co/HHGcJqVL2T

03 Dec 2021

Reply Repost Favourite

RT @Phoniatrics13: Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: prelimi…

14 Aug 2021

Reply Repost Favourite

RT @Phoniatrics13: Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: prelimi…

14 Aug 2021

Reply Repost Favourite

Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial. https://t.co/GEzvxeQEyZ The LSVT® LOUD was more there

14 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.